financetom
Business
financetom
/
Business
/
Registrar Corp Acquires CMC Medical Devices to Make Global Compliance Quick and Easy
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Registrar Corp Acquires CMC Medical Devices to Make Global Compliance Quick and Easy
Nov 5, 2025 4:16 AM

Expands Registrar Corp’s reach to support over 75% of the global medical device market.

MALAGA, Spain & HAMPTON, Va.--(BUSINESS WIRE)--

Registrar Corp, a global leader in regulatory compliance and technology solutions and a Paine Schwartz Partners portfolio company, today announced the acquisition of CMC Medical Devices (CMC), a Spain-based provider of medical device regulatory, clinical, and compliance consulting services. The combination of Registrar Corp’s global network and CMC’s clinical and technical expertise creates a unified partner to help medical device and in vitro diagnostic (IVD) manufacturers bring products to market faster and with greater confidence.

“We’re proud to welcome CMC Medical Devices to the Registrar Corp family,” said Raj Shah, CEO of Registrar Corp. “Together, we offer medical device manufacturers a single partner to navigate complex regulations and access the U.S., EU, and other key global markets—so they can focus on innovation rather than compliance.”

“Joining Registrar Corp enables us to deliver even greater value to our clients,” said Manuel Mateos, CEO of CMC Medical Devices. “Our shared mission is to help manufacturers reach patients faster with trusted, region-specific compliance support.”

The acquisition expands Registrar Corp’s capabilities across multiple service areas, including:

Global Representation: Authorized representative and sponsor services in the EU, UK, Switzerland, Australia, the United States, and China, helping manufacturers maintain compliance in every market.

Export and Market Access Support: Management of Free Sale Certificates (FSCs) from major jurisdictions to streamline export documentation and accelerate product approvals.

Clinical and Regulatory Support: Through CMC’s clinical partner network, Registrar Corp now offers clinical evaluation documentation, data collection planning, post-market clinical follow-up (PMCF) reporting, and comprehensive MDR/IVDR guidance.

This acquisition reinforces Registrar Corp’s commitment to simplifying international expansion for manufacturers—reducing complexity, cost, and time to market. With integrated regulatory, clinical, and compliance services, medical device and IVD companies can now rely on one trusted partner for every stage of product compliance and commercialization.

About Registrar Corp

Registrar Corp provides regulatory compliance and technology solutions to over 32,000 clients across 190 countries, supporting industries including medical devices, food and beverage, cosmetics, and over-the-counter drugs.

About CMC Medical Devices

CMC Medical Devices is a global regulatory consulting firm serving medical device and IVD manufacturers in more than 70 countries, specializing in MDR and IVDR compliance, authorized representation, and regulatory strategy.

Source: Registrar Corp

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Apple to Let Developers Sell Apps Directly From Own Websites to EU Users
Apple to Let Developers Sell Apps Directly From Own Websites to EU Users
Mar 12, 2024
09:34 AM EDT, 03/12/2024 (MT Newswires) -- Apple ( AAPL ) said Tuesday it will allow developers to distribute apps in the European Union directly from their websites or from alternative marketplaces, rather than only through the Apple Store. Web distribution in 27 European Union nations will begin following a software update later this spring. The company also said that...
Lakeland Financial Insider Sold Shares Worth $350,237, According to a Recent SEC Filing
Lakeland Financial Insider Sold Shares Worth $350,237, According to a Recent SEC Filing
Mar 12, 2024
09:36 AM EDT, 03/12/2024 (MT Newswires) -- Eric H Ottinger, Executive Vice President, on March 11, 2024, sold 5,247 shares in Lakeland Financial ( LKFN ) for $350,237. Following the Form 4 filing with the SEC, Ottinger has control over a total of 39,446 shares of the company, with 36,475 shares held directly and 2,971 shares controlled indirectly. SEC Filing:...
Abercrombie & Fitch Co /de/ Insider Sold Shares Worth $382,004, According to a Recent SEC Filing
Abercrombie & Fitch Co /de/ Insider Sold Shares Worth $382,004, According to a Recent SEC Filing
Mar 12, 2024
09:32 AM EDT, 03/12/2024 (MT Newswires) -- Kerrii B Anderson, Director, on March 08, 2024, sold 3,000 shares in Abercrombie & Fitch Co ( ANF ) /de/ (ANF) for $382,004. Following the Form 4 filing with the SEC, Anderson has control over a total of 45,878 shares of the company, with 45,878 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1018840/000122520824004077/xslF345X03/doc4.xml Price: 116.89,...
IDEAYA Biosciences, Merck Sign Deal to Evaluate IDE161 in Combination with Keytruda to Treat Endometrial Cancer Patients
IDEAYA Biosciences, Merck Sign Deal to Evaluate IDE161 in Combination with Keytruda to Treat Endometrial Cancer Patients
Mar 12, 2024
09:35 AM EDT, 03/12/2024 (MT Newswires) -- IDEAYA Biosciences ( IDYA ) said Tuesday that it has signed a clinical trial collaboration and supply deal with Merck ( MRK ) to evaluate IDE161 in combination with Merck's ( MRK ) Keytruda to treat patients with endometrial cancer in a phase 1 clinical trial. Financial terms were not disclosed. Under the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved